In The News
HepQuant and our liver function experts have been featured in numerous news interviews and medical publications in recent years. The following is a partial list of news stories and articles in which we have been involved:
2022
- Oct. 28 – HepQuant Named One of Colorado’s Best Health Diagnostics Companies | Best Startups
- Sep. 12 – Hepion Pharma Announces First Dosing in Phase 2b Clinical Trial with HepQuant Endpoints
- June 2 – Tackling Liver Disease with a Multimodal Cyclophilin Inhibitor | pharma’s almanac
- Mar. 24 – Statins Show Promise for Advanced Liver Failure and Cirrhosis | Gastroenterology & Endoscopy News
- May 3 – Hepion Pharmaceuticals Announces Clinical Collaboration with HepQuant in Phase 2b NASH Trial
2021
2019
2018
- 7/31/18 Hep C Expert Interview: Gregory T. Everson, MD (PatientCareOnline – ModernMedicine Network) | PDF Download
2017
- Dec 2017 Greg Everson Retires After Pioneering Career | PDF Download
- 6/22/17 History of a Cure
2016
- 2/11/16 Developing Tests to Assess Liver Function in NASH and Cirrhosis (Galectin Therapeutics CEO Perspectives)
- 2/11/16 Colorado OEDIT Grants $4.6M to Colorado Organizations (Colorado Bioscience Association)
